nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—ACHE—breast cancer	0.289	0.55	CbGaD
Neostigmine—BCHE—breast cancer	0.17	0.323	CbGaD
Neostigmine—ACHE—Irinotecan—breast cancer	0.0734	0.247	CbGbCtD
Neostigmine—ABCB1—breast cancer	0.0665	0.127	CbGaD
Neostigmine—BCHE—Irinotecan—breast cancer	0.0442	0.149	CbGbCtD
Neostigmine—ABCB1—Toremifene—breast cancer	0.04	0.135	CbGbCtD
Neostigmine—ABCB1—Lapatinib—breast cancer	0.0292	0.0982	CbGbCtD
Neostigmine—ABCB1—Vinorelbine—breast cancer	0.0162	0.0544	CbGbCtD
Neostigmine—ABCB1—Tamoxifen—breast cancer	0.0146	0.0492	CbGbCtD
Neostigmine—ABCB1—Mitoxantrone—breast cancer	0.0143	0.0479	CbGbCtD
Neostigmine—ABCB1—Gemcitabine—breast cancer	0.0126	0.0423	CbGbCtD
Neostigmine—ABCB1—Paclitaxel—breast cancer	0.0114	0.0383	CbGbCtD
Neostigmine—ABCB1—Irinotecan—breast cancer	0.0112	0.0377	CbGbCtD
Neostigmine—ABCB1—Vinblastine—breast cancer	0.00997	0.0336	CbGbCtD
Neostigmine—ABCB1—Docetaxel—breast cancer	0.00822	0.0277	CbGbCtD
Neostigmine—ABCB1—Doxorubicin—breast cancer	0.00613	0.0206	CbGbCtD
Neostigmine—ABCB1—Methotrexate—breast cancer	0.00594	0.02	CbGbCtD
Neostigmine—Demecarium—ACHE—breast cancer	0.00126	0.213	CrCbGaD
Neostigmine—Pyridostigmine—ACHE—breast cancer	0.000809	0.137	CrCbGaD
Neostigmine—Demecarium—BCHE—breast cancer	0.000738	0.125	CrCbGaD
Neostigmine—Edrophonium—ACHE—breast cancer	0.000659	0.112	CrCbGaD
Neostigmine—Rivastigmine—ACHE—breast cancer	0.000613	0.104	CrCbGaD
Neostigmine—Pyridostigmine—BCHE—breast cancer	0.000476	0.0808	CrCbGaD
Neostigmine—Edrophonium—BCHE—breast cancer	0.000388	0.0658	CrCbGaD
Neostigmine—Rivastigmine—BCHE—breast cancer	0.00036	0.0612	CrCbGaD
Neostigmine—Pyridostigmine—CYP3A4—breast cancer	0.000224	0.038	CrCbGaD
Neostigmine—Rivastigmine—CYP2D6—breast cancer	0.000198	0.0336	CrCbGaD
Neostigmine—Rivastigmine—CYP3A4—breast cancer	0.00017	0.0288	CrCbGaD
Neostigmine—Nervous system disorder—Paclitaxel—breast cancer	8.13e-05	0.000667	CcSEcCtD
Neostigmine—Tachycardia—Paclitaxel—breast cancer	8.09e-05	0.000664	CcSEcCtD
Neostigmine—Urticaria—Mitoxantrone—breast cancer	8.08e-05	0.000663	CcSEcCtD
Neostigmine—Diarrhoea—Thiotepa—breast cancer	8.06e-05	0.000661	CcSEcCtD
Neostigmine—Skin disorder—Paclitaxel—breast cancer	8.05e-05	0.000661	CcSEcCtD
Neostigmine—Abdominal pain—Irinotecan—breast cancer	8.04e-05	0.00066	CcSEcCtD
Neostigmine—Abdominal pain—Mitoxantrone—breast cancer	8.04e-05	0.00066	CcSEcCtD
Neostigmine—Muscle spasms—Capecitabine—breast cancer	8.02e-05	0.000658	CcSEcCtD
Neostigmine—Hyperhidrosis—Paclitaxel—breast cancer	8.02e-05	0.000658	CcSEcCtD
Neostigmine—Drowsiness—Methotrexate—breast cancer	7.94e-05	0.000652	CcSEcCtD
Neostigmine—Vomiting—Vinorelbine—breast cancer	7.84e-05	0.000643	CcSEcCtD
Neostigmine—Dizziness—Thiotepa—breast cancer	7.79e-05	0.000639	CcSEcCtD
Neostigmine—Rash—Vinorelbine—breast cancer	7.77e-05	0.000638	CcSEcCtD
Neostigmine—Dermatitis—Vinorelbine—breast cancer	7.77e-05	0.000637	CcSEcCtD
Neostigmine—Hypotension—Paclitaxel—breast cancer	7.75e-05	0.000636	CcSEcCtD
Neostigmine—Urticaria—Fluorouracil—breast cancer	7.74e-05	0.000635	CcSEcCtD
Neostigmine—Headache—Vinorelbine—breast cancer	7.72e-05	0.000634	CcSEcCtD
Neostigmine—Syncope—Docetaxel—breast cancer	7.72e-05	0.000634	CcSEcCtD
Neostigmine—Pollakiuria—Epirubicin—breast cancer	7.7e-05	0.000632	CcSEcCtD
Neostigmine—Loss of consciousness—Docetaxel—breast cancer	7.57e-05	0.000621	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Paclitaxel—breast cancer	7.55e-05	0.00062	CcSEcCtD
Neostigmine—Insomnia—Paclitaxel—breast cancer	7.5e-05	0.000616	CcSEcCtD
Neostigmine—Hypersensitivity—Mitoxantrone—breast cancer	7.49e-05	0.000615	CcSEcCtD
Neostigmine—Hypersensitivity—Irinotecan—breast cancer	7.49e-05	0.000615	CcSEcCtD
Neostigmine—Vomiting—Thiotepa—breast cancer	7.49e-05	0.000614	CcSEcCtD
Neostigmine—Syncope—Capecitabine—breast cancer	7.48e-05	0.000614	CcSEcCtD
Neostigmine—Convulsion—Docetaxel—breast cancer	7.46e-05	0.000612	CcSEcCtD
Neostigmine—Drowsiness—Epirubicin—breast cancer	7.43e-05	0.00061	CcSEcCtD
Neostigmine—Rash—Thiotepa—breast cancer	7.42e-05	0.000609	CcSEcCtD
Neostigmine—Dermatitis—Thiotepa—breast cancer	7.42e-05	0.000609	CcSEcCtD
Neostigmine—Dyspnoea—Paclitaxel—breast cancer	7.39e-05	0.000607	CcSEcCtD
Neostigmine—Headache—Thiotepa—breast cancer	7.38e-05	0.000605	CcSEcCtD
Neostigmine—Somnolence—Paclitaxel—breast cancer	7.37e-05	0.000605	CcSEcCtD
Neostigmine—Arthralgia—Docetaxel—breast cancer	7.33e-05	0.000602	CcSEcCtD
Neostigmine—Loss of consciousness—Capecitabine—breast cancer	7.33e-05	0.000601	CcSEcCtD
Neostigmine—Nausea—Vinorelbine—breast cancer	7.32e-05	0.000601	CcSEcCtD
Neostigmine—Asthenia—Mitoxantrone—breast cancer	7.29e-05	0.000599	CcSEcCtD
Neostigmine—Asthenia—Irinotecan—breast cancer	7.29e-05	0.000599	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	7.28e-05	0.000598	CcSEcCtD
Neostigmine—Hypersensitivity—Fluorouracil—breast cancer	7.17e-05	0.000589	CcSEcCtD
Neostigmine—Dry mouth—Docetaxel—breast cancer	7.17e-05	0.000588	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Paclitaxel—breast cancer	7.16e-05	0.000588	CcSEcCtD
Neostigmine—Pollakiuria—Doxorubicin—breast cancer	7.13e-05	0.000585	CcSEcCtD
Neostigmine—Asthenia—Gemcitabine—breast cancer	7.11e-05	0.000583	CcSEcCtD
Neostigmine—Arthralgia—Capecitabine—breast cancer	7.1e-05	0.000583	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	7.05e-05	0.000579	CcSEcCtD
Neostigmine—Urinary tract disorder—Methotrexate—breast cancer	7.04e-05	0.000578	CcSEcCtD
Neostigmine—Anaphylactic shock—Docetaxel—breast cancer	7.03e-05	0.000577	CcSEcCtD
Neostigmine—Pruritus—Gemcitabine—breast cancer	7.01e-05	0.000575	CcSEcCtD
Neostigmine—Nausea—Thiotepa—breast cancer	6.99e-05	0.000574	CcSEcCtD
Neostigmine—Urethral disorder—Methotrexate—breast cancer	6.99e-05	0.000574	CcSEcCtD
Neostigmine—Diarrhoea—Mitoxantrone—breast cancer	6.96e-05	0.000571	CcSEcCtD
Neostigmine—Diarrhoea—Irinotecan—breast cancer	6.96e-05	0.000571	CcSEcCtD
Neostigmine—Dry mouth—Capecitabine—breast cancer	6.94e-05	0.00057	CcSEcCtD
Neostigmine—Shock—Docetaxel—breast cancer	6.91e-05	0.000568	CcSEcCtD
Neostigmine—Nervous system disorder—Docetaxel—breast cancer	6.89e-05	0.000566	CcSEcCtD
Neostigmine—Pruritus—Fluorouracil—breast cancer	6.89e-05	0.000565	CcSEcCtD
Neostigmine—Drowsiness—Doxorubicin—breast cancer	6.88e-05	0.000564	CcSEcCtD
Neostigmine—Tachycardia—Docetaxel—breast cancer	6.86e-05	0.000563	CcSEcCtD
Neostigmine—Skin disorder—Docetaxel—breast cancer	6.83e-05	0.00056	CcSEcCtD
Neostigmine—Bradycardia—Epirubicin—breast cancer	6.79e-05	0.000557	CcSEcCtD
Neostigmine—Gastrointestinal pain—Paclitaxel—breast cancer	6.78e-05	0.000556	CcSEcCtD
Neostigmine—Diarrhoea—Gemcitabine—breast cancer	6.78e-05	0.000556	CcSEcCtD
Neostigmine—Dizziness—Irinotecan—breast cancer	6.72e-05	0.000552	CcSEcCtD
Neostigmine—Shock—Capecitabine—breast cancer	6.69e-05	0.000549	CcSEcCtD
Neostigmine—Nervous system disorder—Capecitabine—breast cancer	6.67e-05	0.000548	CcSEcCtD
Neostigmine—Diarrhoea—Fluorouracil—breast cancer	6.66e-05	0.000547	CcSEcCtD
Neostigmine—Tachycardia—Capecitabine—breast cancer	6.64e-05	0.000545	CcSEcCtD
Neostigmine—Skin disorder—Capecitabine—breast cancer	6.61e-05	0.000542	CcSEcCtD
Neostigmine—Urinary tract disorder—Epirubicin—breast cancer	6.59e-05	0.000541	CcSEcCtD
Neostigmine—Urticaria—Paclitaxel—breast cancer	6.59e-05	0.000541	CcSEcCtD
Neostigmine—Hyperhidrosis—Capecitabine—breast cancer	6.58e-05	0.00054	CcSEcCtD
Neostigmine—Hypotension—Docetaxel—breast cancer	6.57e-05	0.000539	CcSEcCtD
Neostigmine—Connective tissue disorder—Epirubicin—breast cancer	6.56e-05	0.000538	CcSEcCtD
Neostigmine—Abdominal pain—Paclitaxel—breast cancer	6.55e-05	0.000538	CcSEcCtD
Neostigmine—Urethral disorder—Epirubicin—breast cancer	6.54e-05	0.000537	CcSEcCtD
Neostigmine—Vomiting—Irinotecan—breast cancer	6.46e-05	0.000531	CcSEcCtD
Neostigmine—Vomiting—Mitoxantrone—breast cancer	6.46e-05	0.000531	CcSEcCtD
Neostigmine—Dizziness—Fluorouracil—breast cancer	6.44e-05	0.000528	CcSEcCtD
Neostigmine—Mediastinal disorder—Methotrexate—breast cancer	6.43e-05	0.000527	CcSEcCtD
Neostigmine—Rash—Mitoxantrone—breast cancer	6.41e-05	0.000526	CcSEcCtD
Neostigmine—Rash—Irinotecan—breast cancer	6.41e-05	0.000526	CcSEcCtD
Neostigmine—Dermatitis—Mitoxantrone—breast cancer	6.4e-05	0.000526	CcSEcCtD
Neostigmine—Dermatitis—Irinotecan—breast cancer	6.4e-05	0.000526	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Docetaxel—breast cancer	6.4e-05	0.000526	CcSEcCtD
Neostigmine—Headache—Mitoxantrone—breast cancer	6.37e-05	0.000523	CcSEcCtD
Neostigmine—Headache—Irinotecan—breast cancer	6.37e-05	0.000523	CcSEcCtD
Neostigmine—Hypotension—Capecitabine—breast cancer	6.36e-05	0.000522	CcSEcCtD
Neostigmine—Insomnia—Docetaxel—breast cancer	6.36e-05	0.000522	CcSEcCtD
Neostigmine—Vomiting—Gemcitabine—breast cancer	6.3e-05	0.000517	CcSEcCtD
Neostigmine—Bradycardia—Doxorubicin—breast cancer	6.29e-05	0.000516	CcSEcCtD
Neostigmine—Dyspnoea—Docetaxel—breast cancer	6.27e-05	0.000514	CcSEcCtD
Neostigmine—Somnolence—Docetaxel—breast cancer	6.25e-05	0.000513	CcSEcCtD
Neostigmine—Mental disorder—Methotrexate—breast cancer	6.25e-05	0.000513	CcSEcCtD
Neostigmine—Rash—Gemcitabine—breast cancer	6.24e-05	0.000513	CcSEcCtD
Neostigmine—Dermatitis—Gemcitabine—breast cancer	6.24e-05	0.000512	CcSEcCtD
Neostigmine—Headache—Gemcitabine—breast cancer	6.2e-05	0.000509	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Capecitabine—breast cancer	6.2e-05	0.000509	CcSEcCtD
Neostigmine—Flushing—Epirubicin—breast cancer	6.19e-05	0.000508	CcSEcCtD
Neostigmine—Vomiting—Fluorouracil—breast cancer	6.19e-05	0.000508	CcSEcCtD
Neostigmine—Insomnia—Capecitabine—breast cancer	6.15e-05	0.000505	CcSEcCtD
Neostigmine—Rash—Fluorouracil—breast cancer	6.14e-05	0.000504	CcSEcCtD
Neostigmine—Dermatitis—Fluorouracil—breast cancer	6.13e-05	0.000503	CcSEcCtD
Neostigmine—Hypersensitivity—Paclitaxel—breast cancer	6.11e-05	0.000501	CcSEcCtD
Neostigmine—Headache—Fluorouracil—breast cancer	6.1e-05	0.000501	CcSEcCtD
Neostigmine—Urinary tract disorder—Doxorubicin—breast cancer	6.1e-05	0.0005	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Docetaxel—breast cancer	6.07e-05	0.000498	CcSEcCtD
Neostigmine—Connective tissue disorder—Doxorubicin—breast cancer	6.07e-05	0.000498	CcSEcCtD
Neostigmine—Dyspnoea—Capecitabine—breast cancer	6.07e-05	0.000498	CcSEcCtD
Neostigmine—Urethral disorder—Doxorubicin—breast cancer	6.05e-05	0.000497	CcSEcCtD
Neostigmine—Nausea—Mitoxantrone—breast cancer	6.04e-05	0.000496	CcSEcCtD
Neostigmine—Nausea—Irinotecan—breast cancer	6.04e-05	0.000496	CcSEcCtD
Neostigmine—Mediastinal disorder—Epirubicin—breast cancer	6.01e-05	0.000494	CcSEcCtD
Neostigmine—Arrhythmia—Epirubicin—breast cancer	5.96e-05	0.000489	CcSEcCtD
Neostigmine—Asthenia—Paclitaxel—breast cancer	5.95e-05	0.000488	CcSEcCtD
Neostigmine—Nausea—Gemcitabine—breast cancer	5.88e-05	0.000483	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Capecitabine—breast cancer	5.87e-05	0.000482	CcSEcCtD
Neostigmine—Pruritus—Paclitaxel—breast cancer	5.87e-05	0.000481	CcSEcCtD
Neostigmine—Mental disorder—Epirubicin—breast cancer	5.85e-05	0.00048	CcSEcCtD
Neostigmine—Nausea—Fluorouracil—breast cancer	5.78e-05	0.000475	CcSEcCtD
Neostigmine—Gastrointestinal pain—Docetaxel—breast cancer	5.75e-05	0.000472	CcSEcCtD
Neostigmine—Flushing—Doxorubicin—breast cancer	5.73e-05	0.00047	CcSEcCtD
Neostigmine—Flatulence—Epirubicin—breast cancer	5.72e-05	0.00047	CcSEcCtD
Neostigmine—Diarrhoea—Paclitaxel—breast cancer	5.67e-05	0.000466	CcSEcCtD
Neostigmine—Muscle spasms—Epirubicin—breast cancer	5.58e-05	0.000458	CcSEcCtD
Neostigmine—Gastrointestinal pain—Capecitabine—breast cancer	5.56e-05	0.000457	CcSEcCtD
Neostigmine—Mediastinal disorder—Doxorubicin—breast cancer	5.56e-05	0.000457	CcSEcCtD
Neostigmine—Abdominal pain—Docetaxel—breast cancer	5.56e-05	0.000456	CcSEcCtD
Neostigmine—Arrhythmia—Doxorubicin—breast cancer	5.52e-05	0.000453	CcSEcCtD
Neostigmine—Dizziness—Paclitaxel—breast cancer	5.48e-05	0.00045	CcSEcCtD
Neostigmine—Mental disorder—Doxorubicin—breast cancer	5.41e-05	0.000444	CcSEcCtD
Neostigmine—Urticaria—Capecitabine—breast cancer	5.41e-05	0.000444	CcSEcCtD
Neostigmine—Abdominal pain—Capecitabine—breast cancer	5.38e-05	0.000441	CcSEcCtD
Neostigmine—Convulsion—Methotrexate—breast cancer	5.38e-05	0.000441	CcSEcCtD
Neostigmine—Agitation—Epirubicin—breast cancer	5.34e-05	0.000438	CcSEcCtD
Neostigmine—Flatulence—Doxorubicin—breast cancer	5.3e-05	0.000435	CcSEcCtD
Neostigmine—Arthralgia—Methotrexate—breast cancer	5.28e-05	0.000434	CcSEcCtD
Neostigmine—Vomiting—Paclitaxel—breast cancer	5.27e-05	0.000433	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.25e-05	0.000431	CcSEcCtD
Neostigmine—Rash—Paclitaxel—breast cancer	5.23e-05	0.000429	CcSEcCtD
Neostigmine—Dermatitis—Paclitaxel—breast cancer	5.22e-05	0.000429	CcSEcCtD
Neostigmine—Syncope—Epirubicin—breast cancer	5.21e-05	0.000428	CcSEcCtD
Neostigmine—Headache—Paclitaxel—breast cancer	5.19e-05	0.000426	CcSEcCtD
Neostigmine—Hypersensitivity—Docetaxel—breast cancer	5.18e-05	0.000425	CcSEcCtD
Neostigmine—Muscle spasms—Doxorubicin—breast cancer	5.17e-05	0.000424	CcSEcCtD
Neostigmine—Loss of consciousness—Epirubicin—breast cancer	5.11e-05	0.000419	CcSEcCtD
Neostigmine—Anaphylactic shock—Methotrexate—breast cancer	5.07e-05	0.000416	CcSEcCtD
Neostigmine—Asthenia—Docetaxel—breast cancer	5.04e-05	0.000414	CcSEcCtD
Neostigmine—Convulsion—Epirubicin—breast cancer	5.03e-05	0.000413	CcSEcCtD
Neostigmine—Hypersensitivity—Capecitabine—breast cancer	5.01e-05	0.000411	CcSEcCtD
Neostigmine—Pruritus—Docetaxel—breast cancer	4.97e-05	0.000408	CcSEcCtD
Neostigmine—Nervous system disorder—Methotrexate—breast cancer	4.97e-05	0.000408	CcSEcCtD
Neostigmine—Arthralgia—Epirubicin—breast cancer	4.94e-05	0.000406	CcSEcCtD
Neostigmine—Agitation—Doxorubicin—breast cancer	4.94e-05	0.000405	CcSEcCtD
Neostigmine—Nausea—Paclitaxel—breast cancer	4.93e-05	0.000404	CcSEcCtD
Neostigmine—Skin disorder—Methotrexate—breast cancer	4.92e-05	0.000404	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.91e-05	0.000403	CcSEcCtD
Neostigmine—Hyperhidrosis—Methotrexate—breast cancer	4.9e-05	0.000402	CcSEcCtD
Neostigmine—Asthenia—Capecitabine—breast cancer	4.88e-05	0.000401	CcSEcCtD
Neostigmine—Dry mouth—Epirubicin—breast cancer	4.84e-05	0.000397	CcSEcCtD
Neostigmine—Syncope—Doxorubicin—breast cancer	4.82e-05	0.000396	CcSEcCtD
Neostigmine—Pruritus—Capecitabine—breast cancer	4.81e-05	0.000395	CcSEcCtD
Neostigmine—Diarrhoea—Docetaxel—breast cancer	4.81e-05	0.000395	CcSEcCtD
Neostigmine—Anaphylactic shock—Epirubicin—breast cancer	4.74e-05	0.000389	CcSEcCtD
Neostigmine—Hypotension—Methotrexate—breast cancer	4.73e-05	0.000388	CcSEcCtD
Neostigmine—Loss of consciousness—Doxorubicin—breast cancer	4.72e-05	0.000388	CcSEcCtD
Neostigmine—Shock—Epirubicin—breast cancer	4.66e-05	0.000383	CcSEcCtD
Neostigmine—Convulsion—Doxorubicin—breast cancer	4.66e-05	0.000382	CcSEcCtD
Neostigmine—Diarrhoea—Capecitabine—breast cancer	4.66e-05	0.000382	CcSEcCtD
Neostigmine—Nervous system disorder—Epirubicin—breast cancer	4.65e-05	0.000382	CcSEcCtD
Neostigmine—Dizziness—Docetaxel—breast cancer	4.65e-05	0.000381	CcSEcCtD
Neostigmine—Tachycardia—Epirubicin—breast cancer	4.63e-05	0.00038	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Methotrexate—breast cancer	4.62e-05	0.000379	CcSEcCtD
Neostigmine—Skin disorder—Epirubicin—breast cancer	4.6e-05	0.000378	CcSEcCtD
Neostigmine—Hyperhidrosis—Epirubicin—breast cancer	4.58e-05	0.000376	CcSEcCtD
Neostigmine—Insomnia—Methotrexate—breast cancer	4.58e-05	0.000376	CcSEcCtD
Neostigmine—Arthralgia—Doxorubicin—breast cancer	4.58e-05	0.000376	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.54e-05	0.000373	CcSEcCtD
Neostigmine—Dyspnoea—Methotrexate—breast cancer	4.52e-05	0.000371	CcSEcCtD
Neostigmine—Somnolence—Methotrexate—breast cancer	4.5e-05	0.00037	CcSEcCtD
Neostigmine—Dizziness—Capecitabine—breast cancer	4.5e-05	0.000369	CcSEcCtD
Neostigmine—Dry mouth—Doxorubicin—breast cancer	4.47e-05	0.000367	CcSEcCtD
Neostigmine—Vomiting—Docetaxel—breast cancer	4.47e-05	0.000367	CcSEcCtD
Neostigmine—Rash—Docetaxel—breast cancer	4.43e-05	0.000364	CcSEcCtD
Neostigmine—Hypotension—Epirubicin—breast cancer	4.43e-05	0.000364	CcSEcCtD
Neostigmine—Dermatitis—Docetaxel—breast cancer	4.43e-05	0.000363	CcSEcCtD
Neostigmine—Headache—Docetaxel—breast cancer	4.4e-05	0.000361	CcSEcCtD
Neostigmine—Anaphylactic shock—Doxorubicin—breast cancer	4.39e-05	0.00036	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Methotrexate—breast cancer	4.37e-05	0.000359	CcSEcCtD
Neostigmine—Vomiting—Capecitabine—breast cancer	4.33e-05	0.000355	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Epirubicin—breast cancer	4.32e-05	0.000354	CcSEcCtD
Neostigmine—Shock—Doxorubicin—breast cancer	4.32e-05	0.000354	CcSEcCtD
Neostigmine—Nervous system disorder—Doxorubicin—breast cancer	4.3e-05	0.000353	CcSEcCtD
Neostigmine—Rash—Capecitabine—breast cancer	4.29e-05	0.000352	CcSEcCtD
Neostigmine—Insomnia—Epirubicin—breast cancer	4.29e-05	0.000352	CcSEcCtD
Neostigmine—Dermatitis—Capecitabine—breast cancer	4.29e-05	0.000352	CcSEcCtD
Neostigmine—Tachycardia—Doxorubicin—breast cancer	4.28e-05	0.000351	CcSEcCtD
Neostigmine—Headache—Capecitabine—breast cancer	4.26e-05	0.00035	CcSEcCtD
Neostigmine—Skin disorder—Doxorubicin—breast cancer	4.26e-05	0.00035	CcSEcCtD
Neostigmine—Hyperhidrosis—Doxorubicin—breast cancer	4.24e-05	0.000348	CcSEcCtD
Neostigmine—Dyspnoea—Epirubicin—breast cancer	4.23e-05	0.000347	CcSEcCtD
Neostigmine—Somnolence—Epirubicin—breast cancer	4.21e-05	0.000346	CcSEcCtD
Neostigmine—Nausea—Docetaxel—breast cancer	4.17e-05	0.000343	CcSEcCtD
Neostigmine—Gastrointestinal pain—Methotrexate—breast cancer	4.14e-05	0.00034	CcSEcCtD
Neostigmine—Hypotension—Doxorubicin—breast cancer	4.1e-05	0.000336	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Epirubicin—breast cancer	4.09e-05	0.000336	CcSEcCtD
Neostigmine—Nausea—Capecitabine—breast cancer	4.04e-05	0.000332	CcSEcCtD
Neostigmine—Urticaria—Methotrexate—breast cancer	4.02e-05	0.00033	CcSEcCtD
Neostigmine—Abdominal pain—Methotrexate—breast cancer	4e-05	0.000329	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Doxorubicin—breast cancer	4e-05	0.000328	CcSEcCtD
Neostigmine—Insomnia—Doxorubicin—breast cancer	3.97e-05	0.000326	CcSEcCtD
Neostigmine—Dyspnoea—Doxorubicin—breast cancer	3.91e-05	0.000321	CcSEcCtD
Neostigmine—Somnolence—Doxorubicin—breast cancer	3.9e-05	0.00032	CcSEcCtD
Neostigmine—Gastrointestinal pain—Epirubicin—breast cancer	3.88e-05	0.000318	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Doxorubicin—breast cancer	3.79e-05	0.000311	CcSEcCtD
Neostigmine—Urticaria—Epirubicin—breast cancer	3.77e-05	0.000309	CcSEcCtD
Neostigmine—Abdominal pain—Epirubicin—breast cancer	3.75e-05	0.000308	CcSEcCtD
Neostigmine—Hypersensitivity—Methotrexate—breast cancer	3.73e-05	0.000306	CcSEcCtD
Neostigmine—Asthenia—Methotrexate—breast cancer	3.63e-05	0.000298	CcSEcCtD
Neostigmine—Gastrointestinal pain—Doxorubicin—breast cancer	3.59e-05	0.000294	CcSEcCtD
Neostigmine—Pruritus—Methotrexate—breast cancer	3.58e-05	0.000294	CcSEcCtD
Neostigmine—Hypersensitivity—Epirubicin—breast cancer	3.49e-05	0.000287	CcSEcCtD
Neostigmine—Urticaria—Doxorubicin—breast cancer	3.48e-05	0.000286	CcSEcCtD
Neostigmine—Abdominal pain—Doxorubicin—breast cancer	3.47e-05	0.000285	CcSEcCtD
Neostigmine—Diarrhoea—Methotrexate—breast cancer	3.47e-05	0.000284	CcSEcCtD
Neostigmine—Asthenia—Epirubicin—breast cancer	3.4e-05	0.000279	CcSEcCtD
Neostigmine—Pruritus—Epirubicin—breast cancer	3.35e-05	0.000275	CcSEcCtD
Neostigmine—Dizziness—Methotrexate—breast cancer	3.35e-05	0.000275	CcSEcCtD
Neostigmine—Diarrhoea—Epirubicin—breast cancer	3.24e-05	0.000266	CcSEcCtD
Neostigmine—Hypersensitivity—Doxorubicin—breast cancer	3.23e-05	0.000265	CcSEcCtD
Neostigmine—Vomiting—Methotrexate—breast cancer	3.22e-05	0.000264	CcSEcCtD
Neostigmine—Rash—Methotrexate—breast cancer	3.19e-05	0.000262	CcSEcCtD
Neostigmine—Dermatitis—Methotrexate—breast cancer	3.19e-05	0.000262	CcSEcCtD
Neostigmine—Headache—Methotrexate—breast cancer	3.17e-05	0.00026	CcSEcCtD
Neostigmine—Asthenia—Doxorubicin—breast cancer	3.15e-05	0.000258	CcSEcCtD
Neostigmine—Dizziness—Epirubicin—breast cancer	3.13e-05	0.000257	CcSEcCtD
Neostigmine—Pruritus—Doxorubicin—breast cancer	3.1e-05	0.000255	CcSEcCtD
Neostigmine—Vomiting—Epirubicin—breast cancer	3.01e-05	0.000247	CcSEcCtD
Neostigmine—Nausea—Methotrexate—breast cancer	3.01e-05	0.000247	CcSEcCtD
Neostigmine—Diarrhoea—Doxorubicin—breast cancer	3e-05	0.000246	CcSEcCtD
Neostigmine—Rash—Epirubicin—breast cancer	2.99e-05	0.000245	CcSEcCtD
Neostigmine—Dermatitis—Epirubicin—breast cancer	2.99e-05	0.000245	CcSEcCtD
Neostigmine—Headache—Epirubicin—breast cancer	2.97e-05	0.000244	CcSEcCtD
Neostigmine—Dizziness—Doxorubicin—breast cancer	2.9e-05	0.000238	CcSEcCtD
Neostigmine—Nausea—Epirubicin—breast cancer	2.82e-05	0.000231	CcSEcCtD
Neostigmine—Vomiting—Doxorubicin—breast cancer	2.79e-05	0.000229	CcSEcCtD
Neostigmine—Rash—Doxorubicin—breast cancer	2.77e-05	0.000227	CcSEcCtD
Neostigmine—Dermatitis—Doxorubicin—breast cancer	2.76e-05	0.000227	CcSEcCtD
Neostigmine—Headache—Doxorubicin—breast cancer	2.75e-05	0.000226	CcSEcCtD
Neostigmine—Nausea—Doxorubicin—breast cancer	2.61e-05	0.000214	CcSEcCtD
Neostigmine—ABCB1—Metabolism—CHST9—breast cancer	1.87e-05	0.000374	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC2A2—breast cancer	1.86e-05	0.000371	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.84e-05	0.000367	CbGpPWpGaD
Neostigmine—ACHE—Transmission across Chemical Synapses—HRAS—breast cancer	1.83e-05	0.000366	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ABCG2—breast cancer	1.82e-05	0.000364	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CPT1A—breast cancer	1.82e-05	0.000364	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—MTR—breast cancer	1.82e-05	0.000364	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MMP1—breast cancer	1.82e-05	0.000364	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.8e-05	0.00036	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	1.78e-05	0.000357	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HPGDS—breast cancer	1.78e-05	0.000357	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HBA1—breast cancer	1.77e-05	0.000354	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—COX11—breast cancer	1.77e-05	0.000354	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—LEP—breast cancer	1.76e-05	0.000352	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	1.75e-05	0.000351	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—DPYD—breast cancer	1.75e-05	0.000349	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MED12—breast cancer	1.75e-05	0.000349	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTT1—breast cancer	1.73e-05	0.000346	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC2A2—breast cancer	1.73e-05	0.000345	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALDOA—breast cancer	1.72e-05	0.000344	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—AKT1—breast cancer	1.71e-05	0.000342	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ABCG2—breast cancer	1.69e-05	0.000338	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.68e-05	0.000336	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOA3—breast cancer	1.67e-05	0.000334	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC2A2—breast cancer	1.66e-05	0.000331	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.64e-05	0.000328	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP17A1—breast cancer	1.64e-05	0.000327	CbGpPWpGaD
Neostigmine—BCHE—Transmission across Chemical Synapses—HRAS—breast cancer	1.64e-05	0.000327	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CPT1A—breast cancer	1.62e-05	0.000324	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ABCG2—breast cancer	1.62e-05	0.000324	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MTR—breast cancer	1.62e-05	0.000324	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MMP1—breast cancer	1.62e-05	0.000324	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ENO1—breast cancer	1.62e-05	0.000324	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS1—breast cancer	1.62e-05	0.000324	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SHMT1—breast cancer	1.62e-05	0.000324	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CDA—breast cancer	1.62e-05	0.000324	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.62e-05	0.000323	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.59e-05	0.000319	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HPGDS—breast cancer	1.59e-05	0.000318	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2D6—breast cancer	1.59e-05	0.000318	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HBA1—breast cancer	1.58e-05	0.000316	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—LEP—breast cancer	1.57e-05	0.000314	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NCOA2—breast cancer	1.56e-05	0.000312	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC2A5—breast cancer	1.56e-05	0.000312	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLCO1B1—breast cancer	1.56e-05	0.000312	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ACHE—breast cancer	1.54e-05	0.000309	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTT1—breast cancer	1.54e-05	0.000309	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	1.53e-05	0.000306	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—FASN—breast cancer	1.51e-05	0.000303	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	1.51e-05	0.000302	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—BCHE—breast cancer	1.51e-05	0.000301	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—APRT—breast cancer	1.51e-05	0.000301	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—TFRC—breast cancer	1.51e-05	0.000301	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	1.5e-05	0.000301	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC5A5—breast cancer	1.49e-05	0.000298	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	1.49e-05	0.000297	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP17A1—breast cancer	1.46e-05	0.000292	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	1.45e-05	0.000291	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—IGF1—breast cancer	1.45e-05	0.000291	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—NCOA2—breast cancer	1.45e-05	0.00029	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ENO1—breast cancer	1.45e-05	0.000289	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS1—breast cancer	1.45e-05	0.000289	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.44e-05	0.000288	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC2A1—breast cancer	1.44e-05	0.000287	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NQO1—breast cancer	1.44e-05	0.000287	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.42e-05	0.000284	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2D6—breast cancer	1.42e-05	0.000284	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ANGPTL4—breast cancer	1.42e-05	0.000283	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ESRRA—breast cancer	1.42e-05	0.000283	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.41e-05	0.000282	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MMP2—breast cancer	1.41e-05	0.000281	CbGpPWpGaD
Neostigmine—ACHE—Neuronal System—HRAS—breast cancer	1.4e-05	0.000281	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP3A4—breast cancer	1.4e-05	0.00028	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.39e-05	0.000279	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOA2—breast cancer	1.39e-05	0.000278	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC5A5—breast cancer	1.38e-05	0.000277	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP1B1—breast cancer	1.38e-05	0.000276	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	1.38e-05	0.000275	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HSP90AA1—breast cancer	1.35e-05	0.00027	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—FASN—breast cancer	1.35e-05	0.00027	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	1.35e-05	0.00027	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HADHB—breast cancer	1.34e-05	0.000269	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GPI—breast cancer	1.34e-05	0.000269	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	1.34e-05	0.000267	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC5A5—breast cancer	1.33e-05	0.000266	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NCOA1—breast cancer	1.32e-05	0.000263	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	1.31e-05	0.000263	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	1.31e-05	0.000262	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	1.3e-05	0.00026	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—IGF1—breast cancer	1.3e-05	0.000259	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—STK11—breast cancer	1.3e-05	0.000259	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP19A1—breast cancer	1.3e-05	0.000259	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC2A1—breast cancer	1.28e-05	0.000256	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NQO1—breast cancer	1.28e-05	0.000256	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALDH1A1—breast cancer	1.28e-05	0.000256	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALDH7A1—breast cancer	1.28e-05	0.000256	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.27e-05	0.000254	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.27e-05	0.000254	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.26e-05	0.000251	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MMP2—breast cancer	1.26e-05	0.000251	CbGpPWpGaD
Neostigmine—BCHE—Neuronal System—HRAS—breast cancer	1.25e-05	0.00025	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP3A4—breast cancer	1.25e-05	0.00025	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.24e-05	0.000249	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.24e-05	0.000248	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP1B1—breast cancer	1.23e-05	0.000246	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ADSL—breast cancer	1.23e-05	0.000246	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PHGDH—breast cancer	1.23e-05	0.000246	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NME1—breast cancer	1.23e-05	0.000246	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—FHL2—breast cancer	1.23e-05	0.000246	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—UMPS—breast cancer	1.23e-05	0.000246	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.22e-05	0.000244	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.22e-05	0.000243	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HSP90AA1—breast cancer	1.21e-05	0.000241	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—COMT—breast cancer	1.2e-05	0.000241	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HPSE—breast cancer	1.2e-05	0.000241	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—BRIP1—breast cancer	1.2e-05	0.000241	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LDHB—breast cancer	1.2e-05	0.000241	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTP1—breast cancer	1.2e-05	0.00024	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	1.19e-05	0.000238	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HMOX1—breast cancer	1.18e-05	0.000236	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ITPR1—breast cancer	1.18e-05	0.000236	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.18e-05	0.000235	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOA1—breast cancer	1.17e-05	0.000235	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CXCL8—breast cancer	1.17e-05	0.000234	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP19A1—breast cancer	1.16e-05	0.000231	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—STK11—breast cancer	1.16e-05	0.000231	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.15e-05	0.000229	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ABCC1—breast cancer	1.14e-05	0.000228	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HMMR—breast cancer	1.14e-05	0.000228	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA3—breast cancer	1.14e-05	0.000228	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ABCB1—breast cancer	1.14e-05	0.000227	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—TYMS—breast cancer	1.11e-05	0.000223	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARGC1B—breast cancer	1.11e-05	0.000221	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PLA2G4A—breast cancer	1.1e-05	0.00022	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTM1—breast cancer	1.1e-05	0.00022	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NCOR1—breast cancer	1.1e-05	0.00022	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.1e-05	0.00022	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.09e-05	0.000217	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.08e-05	0.000217	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CTNNB1—breast cancer	1.08e-05	0.000216	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—COMT—breast cancer	1.07e-05	0.000215	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTP1—breast cancer	1.07e-05	0.000214	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GPX1—breast cancer	1.06e-05	0.000211	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HMOX1—breast cancer	1.06e-05	0.000211	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.05e-05	0.000211	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ITPR1—breast cancer	1.05e-05	0.00021	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.05e-05	0.00021	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP1A1—breast cancer	1.04e-05	0.000209	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CA9—breast cancer	1.04e-05	0.000209	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA4—breast cancer	1.04e-05	0.000209	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CXCL8—breast cancer	1.04e-05	0.000209	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ERCC2—breast cancer	1.04e-05	0.000207	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.03e-05	0.000206	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA2—breast cancer	1.02e-05	0.000204	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GPX2—breast cancer	1.02e-05	0.000204	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ABCB1—breast cancer	1.01e-05	0.000202	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SULT1A1—breast cancer	1.01e-05	0.000201	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GPX4—breast cancer	1.01e-05	0.000201	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—TYMS—breast cancer	9.95e-06	0.000199	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NCOR1—breast cancer	9.83e-06	0.000197	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTM1—breast cancer	9.83e-06	0.000197	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PLA2G4A—breast cancer	9.83e-06	0.000197	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—IDH1—breast cancer	9.82e-06	0.000196	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTA1—breast cancer	9.82e-06	0.000196	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	9.82e-06	0.000196	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—MTHFR—breast cancer	9.74e-06	0.000195	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	9.74e-06	0.000195	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NAT2—breast cancer	9.71e-06	0.000194	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CTNNB1—breast cancer	9.62e-06	0.000192	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GPX1—breast cancer	9.41e-06	0.000188	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP1A1—breast cancer	9.32e-06	0.000186	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ERCC2—breast cancer	9.24e-06	0.000185	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CAV1—breast cancer	8.98e-06	0.00018	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	8.95e-06	0.000179	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MTHFR—breast cancer	8.69e-06	0.000174	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	8.65e-06	0.000173	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.58e-06	0.000172	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MED12—breast cancer	8.52e-06	0.00017	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—DPYD—breast cancer	8.52e-06	0.00017	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALDOA—breast cancer	8.38e-06	0.000168	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CG—breast cancer	8.18e-06	0.000164	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOA3—breast cancer	8.14e-06	0.000163	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC2A2—breast cancer	8.08e-06	0.000162	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CAV1—breast cancer	8.01e-06	0.00016	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTR—breast cancer	7.92e-06	0.000158	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ABCG2—breast cancer	7.92e-06	0.000158	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CPT1A—breast cancer	7.92e-06	0.000158	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HPGDS—breast cancer	7.76e-06	0.000155	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HBA1—breast cancer	7.72e-06	0.000154	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.66e-06	0.000153	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTT1—breast cancer	7.53e-06	0.000151	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACHE—breast cancer	7.53e-06	0.000151	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	7.31e-06	0.000146	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CG—breast cancer	7.3e-06	0.000146	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CD—breast cancer	7.19e-06	0.000144	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP17A1—breast cancer	7.13e-06	0.000143	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALB—breast cancer	7.1e-06	0.000142	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ENO1—breast cancer	7.06e-06	0.000141	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS1—breast cancer	7.06e-06	0.000141	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2D6—breast cancer	6.92e-06	0.000138	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOA2—breast cancer	6.79e-06	0.000136	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NOS3—breast cancer	6.79e-06	0.000136	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	6.6e-06	0.000132	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—FASN—breast cancer	6.59e-06	0.000132	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—BCHE—breast cancer	6.56e-06	0.000131	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC5A5—breast cancer	6.48e-06	0.00013	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CD—breast cancer	6.42e-06	0.000128	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALB—breast cancer	6.34e-06	0.000127	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CB—breast cancer	6.27e-06	0.000125	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NQO1—breast cancer	6.26e-06	0.000125	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC2A1—breast cancer	6.26e-06	0.000125	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS2—breast cancer	6.21e-06	0.000124	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP3A4—breast cancer	6.1e-06	0.000122	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NOS3—breast cancer	6.06e-06	0.000121	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP1B1—breast cancer	6e-06	0.00012	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	5.97e-06	0.000119	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HSP90AA1—breast cancer	5.88e-06	0.000118	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOA1—breast cancer	5.72e-06	0.000114	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—STK11—breast cancer	5.64e-06	0.000113	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP19A1—breast cancer	5.64e-06	0.000113	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CB—breast cancer	5.59e-06	0.000112	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS2—breast cancer	5.54e-06	0.000111	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTEN—breast cancer	5.42e-06	0.000108	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—COMT—breast cancer	5.24e-06	0.000105	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTP1—breast cancer	5.22e-06	0.000104	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HMOX1—breast cancer	5.15e-06	0.000103	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ITPR1—breast cancer	5.14e-06	0.000103	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—TYMS—breast cancer	4.85e-06	9.7e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTEN—breast cancer	4.83e-06	9.66e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTM1—breast cancer	4.8e-06	9.59e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PLA2G4A—breast cancer	4.8e-06	9.59e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOR1—breast cancer	4.8e-06	9.59e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GPX1—breast cancer	4.59e-06	9.18e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP1A1—breast cancer	4.55e-06	9.09e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ERCC2—breast cancer	4.51e-06	9.02e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTHFR—breast cancer	4.24e-06	8.48e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CAV1—breast cancer	3.91e-06	7.82e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3CA—breast cancer	3.82e-06	7.64e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CG—breast cancer	3.56e-06	7.12e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3CA—breast cancer	3.41e-06	6.82e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CD—breast cancer	3.13e-06	6.26e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKT1—breast cancer	3.12e-06	6.24e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALB—breast cancer	3.09e-06	6.18e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NOS3—breast cancer	2.96e-06	5.91e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKT1—breast cancer	2.79e-06	5.57e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CB—breast cancer	2.73e-06	5.46e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS2—breast cancer	2.7e-06	5.41e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTEN—breast cancer	2.36e-06	4.72e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3CA—breast cancer	1.66e-06	3.33e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKT1—breast cancer	1.36e-06	2.72e-05	CbGpPWpGaD
